SB-705498

DRUG8 trials

Sponsors

GlaxoSmithKline

Conditions

Irritable ColonMigraine, AcuteRhinitis

Phase 1

A Study To Assess The Effect Of SB-705498 In A Capsaicin Challenge Model

CompletedNCT00731250

GlaxoSmithKlineRhinitis

Start: 2008-07-22End: 2009-03-31Updated: 2017-07-13

Intranasal SB-705498 in Healthy Volunteers

CompletedNCT00907933

GlaxoSmithKlineRhinitis

Start: 2008-11-10End: 2009-02-11Updated: 2017-07-13

Phase 2

Use Of SB-705498 In The Acute Treatment Of Migraine

CompletedNCT00269022

GlaxoSmithKlineMigraine, Acute

Start: 2006-01-31Target: 70Updated: 2009-05-18

Sb-705498 Rectal Pain Study

TerminatedNCT00461682

GlaxoSmithKlineIrritable Colon

Start: 2007-01-26End: 2007-09-01Updated: 2018-08-20

Intranasal SB-705498 in Allergic Rhinitis (AR) Patients

CompletedNCT01424397

GlaxoSmithKlineRhinitis

Start: 2011-04-14End: 2011-07-07Updated: 2019-09-13

SB705498 Proof of Concept Chamber Challenge in Subjects With Non Allergic Rhinitis

CompletedNCT01424514

GlaxoSmithKlineRhinitis

Start: 2010-12-01End: 2011-04-18Updated: 2018-01-29

Intranasal SB-705498 in Non-allergic Rhinitis Patients

CompletedNCT01439308

GlaxoSmithKlineRhinitis

Start: 2009-12-31End: 2010-05-31Updated: 2016-12-01

A Study to Investigate the Effect of SB-705498 on Chronic Cough

CompletedNCT01476098

GlaxoSmithKlineRhinitis

Start: 2011-04-30End: 2012-01-31Updated: 2016-12-01